Open Access Policy

The European Journal of Molecular Pharmacy (EJMP) follows a fully open-access publishing model, ensuring that all articles are freely and permanently accessible online immediately upon publication. Readers can read, download, and share the content without any subscription or access charges.

EJMP supports the global dissemination of scientific knowledge and encourages collaboration among researchers, academicians, and industry professionals by providing unrestricted access to high-quality research in molecular pharmacy.

Authors retain the copyright of their work while granting the publisher a non-exclusive license to publish and archive the article. All articles are distributed under the Creative Commons Attribution (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

All articles are assigned a Digital Object Identifier (DOI) to ensure permanent accessibility and accurate citation. The journal also follows standard digital archiving practices to preserve published content. 

Detailed information regarding the Open Access Policy..